Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Weezion SAS

Weezion SAS is the result of a scientific partnership between the teams of the Institute of Infectious Agents at the Croix Rousse Hospital in Lyon, the Institute of Analytical Sciences, and the International Infectious Disease Research Centre of the Claude Bernard Lyon 1 University. Co-founded by François Vandenesch, Jérôme Lemoine and Hervé Brochette, Weezion develops and promotes innovative solutions for the in-vitro diagnosis of micro blood infections, created within the framework of IdBIORIV, winner of the “Hospital-University Research in Health (RHU)” project of the Investments for the Future Program. *


Period Start 2020-09-18 established (s-off)
Products Industry in vitro diagnostics (IVD)
  Industry 2 Weezion dx technology
Person Person Brochette, Hervé (Weezion 202205 CEO + Co-Founder)
Region Region Lyon
  Country France
  Street 30 Route de la Gorge aux Loups
  City 71960 Vergisson
    Address record changed: 2022-06-01
Basic data Employees n. a.
    * Document for »About Section«: Weezion SAS. (6/1/22). "Press Release: Weezion, a French MedTech Start-up, Announces Capital Investment from bioMérieux". Lyon.
Record changed: 2024-03-30


Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Weezion SAS

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px

» top